Searching fir transcriptional regulators of Ang II - Induced vascular pathology

被引:14
作者
Dzau, VJ [1 ]
Lopez-Ilasaca, M
机构
[1] Duke Univ, Med Ctr, Off Chancellor, Dept Med, Durham, NC 27708 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1172/JCI26384
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Ang II plays a key role in cardiovascular regulation and participates in vascular pathobiology, including inflammation and remodeling. Whether these tissue effects are mediated by direct Ang II actions or indirectly as a result of its influence on hemodynamics is being debated. In vitro data have shown that Ang II induces vascular cellular transcriptional activation and gene expression, but the mechanisms explaining its long-term tissue effects in vivo are relatively unknown. Do the multiple in vivo vascular activities elicited by Ang II (such as inflammation, Fibrosis, and vascular cell hypertrophy/proliferation) occur via independent pathways, or do common transcription mechanisms mediate these multiple effects? In this issue, Zhan et al. identify Ets-1 as a critical downstream transcriptional mediator of vascular inflammation and remodeling in vivo; their data suggest that Ets-1 may be a common denominator of a complex process that involves multiple pathways previously considered to be mechanistically independent (see the related article beginning on page 2508). Characterization of the critical transcription programs activated by Ang II in vivo and determination of the hierarchy of responses are vital to the understanding of the mechanism of vascular disease and to the development of therapies targeted at inhibiting the common transcription effectors of vascular pathology.
引用
收藏
页码:2319 / 2322
页数:4
相关论文
共 13 条
[1]   ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS-binding sites of the stromelysin-1 promoter by counteracting autoinhibition [J].
Baillat, D ;
Bègue, A ;
Stéhelin, D ;
Aumercier, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (33) :29386-29398
[2]   Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes [J].
Dandré, F ;
Owens, GK .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (06) :H2042-H2051
[3]   The biology of the Ets1 proto-oncogene [J].
Jürgen Dittmer .
Molecular Cancer, 2 (1)
[4]   Structural analysis of the autoinhibition of Ets-1 and its role in protein partnerships [J].
Garvie, CW ;
Pufall, MA ;
Graves, BJ ;
Wolberger, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (47) :45529-45536
[5]   Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage [J].
Graiani, G ;
Lagrasta, C ;
Migliaccio, E ;
Spillmann, F ;
Meloni, M ;
Madeddu, P ;
Quaini, F ;
Padura, IM ;
Lanfrancone, L ;
Pelicci, P ;
Emanueli, C .
HYPERTENSION, 2005, 46 (02) :433-440
[6]  
Iwasaka C, 1996, J CELL PHYSIOL, V169, P522, DOI 10.1002/(SICI)1097-4652(199612)169:3<522::AID-JCP12>3.0.CO
[7]  
2-7
[8]   Regulation of g protein-coupled receptor kinases and arrestins during receptor desensitization [J].
Kohout, TA ;
Lefkowitz, RJ .
MOLECULAR PHARMACOLOGY, 2003, 63 (01) :9-18
[9]   Muscle-specific signaling mechanism that links actin dynamics to serum response factor [J].
Kuwahara, K ;
Barrientos, T ;
Pipes, GCT ;
Li, S ;
Olson, EN .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (08) :3173-3181
[10]   Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors [J].
Lockman, K ;
Hinson, JS ;
Medlin, MD ;
Morris, D ;
Taylor, JM ;
Mack, CP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (41) :42422-42430